BC Platform, University of Nottingham Partnership, Certis Oncology Launches AI Assistant, More

Vizgen announced the official launch of its Certified Service Provider (CSP) program. The CSP initiative aims to empower researchers around the world by expanding access to Vizgen’s MERSCOPE and MERSCOPE Ultra Platforms for high-quality spatial genomics services through a network of certified academic and commercial services organizations, with the training, expertise and technology infrastructure required to provide full-service Vizgen solutions for breakthrough discoveries. Press release. 

BC Platforms has entered an extended joint partnership with the University of Nottingham (UoN) and Nottingham University Hospitals NHS Trust (NUH) to provide data sharing platforms and tools facilitating data sharing, security, and advanced analyses including Trusted Research Environments (TREs). The outputs of analyzing such data, from both clinical and basic research, have the potential to transform understanding of important healthcare trends, as well as studying devastating diseases, such as cancer and diabetes, up to the population level. They could also potentially help unlock innovative new solutions and therapies for patients everywhere. Press release. 

TetraScience announced its partnership with Snowflake to enable joint customers to unlock the value of their scientific data and reap the benefits of the Scientific AI revolution. The collaboration will allow the seamless sharing of scientific data between the Tetra Scientific Data and AI Cloud and Snowflake’s AI Data Cloud so that life sciences organizations can generate previously unattainable insights with diverse and multimodal datasets, improving their pace and quality of decision-making across the biopharma value chain. Press release. 

Certis Oncology Solutions has commercially launched CertisOI Assistant, an innovative chatbot tool designed to enhance the efficiency and effectiveness of cancer research. This research tool leverages artificial intelligence/machine learning (AI/ML) and OpenAI’s ChatGPT language model to quickly provide researchers with insights into cancer models and drug response, bringing greater precision to early drug development decisions. The CertisOI Assistant works as a natural language intermediary for accessing the genomic and drug sensitivity characterization data associated with thousands of cancer research models, including Certis’ patient-derived xenograft (PDX) models, as well as public cancer cell lines from the Cancer Cell Line Encycolopedia (CCLE). By asking the CertisOI Assistant, users can convert query results into charts and graphs and download summary and detailed data for sharing. Press release. 

Elsevier and Enamine announced a partnership to integrate Enamine’s database of over 43 million make-on-demand (MADE) analog compounds into Reaxys. The integration will provide chemists with access to a diverse array of chemical compounds for accelerated drug discovery and materials science research. Reaxys is a chemical database that combines over a billion chemistry data points from scientific journals and patents with AI to support innovation in drug discovery, chemical R&D, and academia. This new integration combines Enamine's expertise in compound synthesis with the comprehensive capabilities of the Reaxys platform, enabling researchers to access a vast repository of chemical information and facilitating the identification of novel drug targets, biomarkers, and screening compounds. Press release. 

Beckman Coulter Life Sciences has launched the Cydem VT Automated Clone Screening System, a high-throughput microbioreactor platform for automated top clone screening. The new Cydem VT System significantly reduces time to market for biologic drug discovery and monoclonal antibody-based therapeutics by slashing manual laboratory steps in Cell Line Development up to 90% in a single experiment and eliminating the need for many subsequent traditional screening steps. Press release. 

Sapio Sciences announced that evitria has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities. evitria chose Sapio ELN and Sapio Report Builder to streamline complex workflows, and Sapio Report Generator will enable the creation of customized reports directly from the system. Press release. 

QIAGEN has launched two new tools for designing and ordering custom solutions that can be used to support microbial analysis of bacterial, fungal and viral targets. The new tools are a design tool for Custom dPCR Microbial Assays, a first-of-its-kind custom assay design tool that enables users to design primers and probes for their specific microbial targets of interest and is tailored specifically for bacterial, fungal and viral targets. The second tool is QIAseq xHYB Custom Microbial Panels, where researchers can design their assays against many whole genomes at once, allowing them to achieve the highest possible resolution in applications such as microbial detection. Press release. 

Qlucore has launched the newest version of the Qlucore Omics Explorer (QOE) 3.10. QOE is used in research, life sciences, food tech, plant science, and biotechnology, as well as at universities. Users of the software can view and analyze data in a simple and interactive way. Tools and methods for data analysis are selected based on user needs. The results can then easily be presented to colleagues and collaborators. The new version includes an optimized DESeq2 family of methods and statistics, enabling flexible and easy analysis of multi-omics data. Providing enhanced interactivity, the statistical calculations are, as an example, 15 times faster than those performed by R. Press release.